| Literature DB >> 22616579 |
Kathryn M Nelson1, Christine E Salomon, Courtney C Aldrich.
Abstract
The emerging global epidemic of drug-resistant tuberculosis has created an urgent need to identify novel therapeutic approaches for disease treatment. Transvalencin Z (1) is a natural product from Nocardia transvalensis with relatively potent and selective antimycobacterial activity against Mycobacterium smegmatis, making it an attractive target for structure-activity and mechanism of action studies. The total synthesis of the four possible diastereomers of transvalencin Z was completed (1a-d), and the absolute configurations were defined using chemical synthesis, HPLC retention times, and optical rotation measurements. Surprisingly, none of the transvalencin Z diastereomers exhibited any inhibitory activity against a panel of microbial pathogens, including several species of mycobacteria.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22616579 PMCID: PMC3381897 DOI: 10.1021/np200972s
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050